发明名称 Genetisch veränderte Fibroblastenzellen
摘要 Disclosed are genetically modified fibroblast cells having the following characteristics: (a) A gene of the genome thereof is inactivated and/or a component of the signal transduction path is modified by means of a sequence of a modified AP-1 activity, said gene coding for a subunit of the transcription factor AP-1 and said component acting on the transcription factor AP-1. (b) The inventive fibroblast cell contains the gene of (a) in an expression vector and functionally combined with a promoter and in such a form that the active subunit is only expressed after induction of the promoter or the subunit that is coded by the gene is present in the inactive form and can be activated. The invention also relates to a method using the inventive fibroblast cell for identifying a compound that can promote, inhibit or modify the AP-1 dependent differentiation and/or proliferation of keratinocytes or for identifying a gene that takes part in the AP-1 dependent differentiation and/or proliferation of keratinocytes. The invention further relates to the use of the test compound or gene that has been identified by means of the inventive method, for treating or diagnosing diseases which are associated to a disturbed proliferation and/or differentiation of keratinocytes.
申请公布号 DE10011926(A1) 申请公布日期 2001.08.02
申请号 DE20001011926 申请日期 2000.01.14
申请人 DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS 发明人 ANGEL, PETER;FUSENIG, NORBERT;KOLBUS, ANDREA;SCHORPP-KISTNER, MARINA;SZABOWSKI, AXEL;MAAS-SZABOWSKI, NICOLE;ANDRECHT, SVEN
分类号 C12N15/09;A61K39/395;A61K45/00;A61K48/00;A61P17/00;A61P17/02;A61P17/06;A61P29/00;A61P35/00;A61P43/00;C12N5/077;C12N5/10;C12N5/18;C12Q1/02;C12Q1/68;(IPC1-7):C12N5/10 主分类号 C12N15/09
代理机构 代理人
主权项
地址